← Yangiliklar markaziga qaytish
Sog‘liq
FDA Approves First Drug to Treat Neurological Symptoms of Type 3 Gaucher Disease
Manba: U.S. Food and Drug Administration (FDA)
E’lon qilingan:
Tarjima qilinmagan — asl tilda ko‘rsatilgan (ingliz tili).
Manba bergan mazmun — U.S. Food and Drug Administration (FDA)
FDA today approved Infilbray (venglustat) tablets, the first treatment for the neurological symptoms of Type 3 Gaucher disease (GD3) in adults and pediatric patients weighing at least 15 kg (approximately 33 pounds).
Bu sahifada nashriyot bildirgan ma’lumot keltirilgan. MYITEDU bu da’volarni mustaqil tekshirmagan.
Asl maqolani o‘qish — U.S. Food and Drug Administration (FDA) ↗
Manba ko‘rsatilishi: Source: U.S. Food and Drug Administration (fda.gov)
Ulashish
Instagram saytlardan havola ulashishni qo‘llab-quvvatlamaydi. Kartani yuklab oling, Instagram ilovasida joylang va izohni qo‘ying.
Tuzatish haqida xabar berish
Materialdagi, tarjimadagi, sanadagi yoki manba ko‘rsatilishidagi xato haqida xabar bering. Aloqa ma’lumotlaringiz maxfiy saqlanadi va faqat javob berish uchun ishlatiladi.